BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10712944)

  • 1. Lymphoid precursors.
    Akashi K; Reya T; Dalma-Weiszhausz D; Weissman IL
    Curr Opin Immunol; 2000 Apr; 12(2):144-50. PubMed ID: 10712944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of lineage commitment during lymphocyte development.
    Staal FJ; Clevers HC
    Int Rev Immunol; 2001 Feb; 20(1):45-64. PubMed ID: 11342297
    [No Abstract]   [Full Text] [Related]  

  • 3. Lineage commitment in lymphopoiesis.
    Busslinger M; Nutt SL; Rolink AG
    Curr Opin Immunol; 2000 Apr; 12(2):151-8. PubMed ID: 10712946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones.
    Schaniel C; Bruno L; Melchers F; Rolink AG
    Blood; 2002 Jan; 99(2):472-8. PubMed ID: 11781227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.
    Akashi K; Traver D; Miyamoto T; Weissman IL
    Nature; 2000 Mar; 404(6774):193-7. PubMed ID: 10724173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver.
    Douagi I; Colucci F; Di Santo JP; Cumano A
    Blood; 2002 Jan; 99(2):463-71. PubMed ID: 11781226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
    Nutt SL; Heavey B; Rolink AG; Busslinger M
    Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise lineage restriction of progenitors in lympho-myelopoiesis.
    Katsura Y; Kawamoto H
    Int Rev Immunol; 2001 Feb; 20(1):1-20. PubMed ID: 11342295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
    Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
    Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.
    Dias S; Silva H; Cumano A; Vieira P
    J Exp Med; 2005 Mar; 201(6):971-9. PubMed ID: 15767371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell commitment: Pax5 is the deciding factor.
    Enver T
    Curr Biol; 1999 Dec 16-30; 9(24):R933-5. PubMed ID: 10607584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of B-cell lineage commitment.
    Nutt SL; Rolink AG; Busslinger M
    Cold Spring Harb Symp Quant Biol; 1999; 64():51-9. PubMed ID: 11232328
    [No Abstract]   [Full Text] [Related]  

  • 14. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
    Rolink AG; Nutt SL; Melchers F; Busslinger M
    Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology. Wavering on commitment.
    Cory S
    Nature; 1999 Oct; 401(6753):538-9. PubMed ID: 10524616
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of NK1.1 expression during lineage commitment of progenitor thymocytes.
    Carlyle JR; Zúñiga-Pflücker JC
    J Immunol; 1998 Dec; 161(12):6544-51. PubMed ID: 9862680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
    Cotta CV; Zhang Z; Kim HG; Klug CA
    Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
    Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
    J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7Ralpha and E47: independent pathways required for development of multipotent lymphoid progenitors.
    Kee BL; Bain G; Murre C
    EMBO J; 2002 Jan; 21(1-2):103-13. PubMed ID: 11782430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.